Pharmaceutical Executive-11-03-2007
Advertisement
Advertisement
Trending on PharmExec
1
M&A Roundup: Johnson & Johnson Acquires Ollin Biosciences, Eli Lilly Acquires Calytrix Bio, AmyriAD Therpaeutics Acquires AD04 Alzheimers Program, Sanofi Enters Collaboration with Seawolf Therapeutics
2
How Pharma Workflows Are Impacted by Agentic Models Beyond Productivity Gains
3
FDA Approves Cosentyx for Polymyalgia Rheumatica, Wilserdly for ER-Positive ESR1-Mutated Advanced Breast Cancer
4
The Hidden Risk in Pharma’s AI Rush
5
